UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 12b-25

 

Commission File Number

 

NOTIFICATION OF LATE FILING

 
   
   
   
   
   

 

(Check One):    

  ¨   Form 10-K     ¨   Form 11-K     ¨   Form 20-F     x   Form 10-Q
  For Period Ended: September 30, 2007
  ¨   Transition Report on Form 10-K
  ¨   Transition Report on Form 20-F
  ¨   Transition Report on Form 11-K
  ¨   Transition Report on Form 10-Q
  ¨   Transition Report on Form N-SAR
  For the Transition Period Ended:                                                                  

 

 

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:             

 

 
 



Part I – Registrant Information

 

PAINCARE HOLDINGS, INC.
Full Name of Registrant:
 
Former Name if Applicable:
1030 N. Orange Avenue, Ste. 105
Address of Principal Executive Office (Street and Number) :
Orlando, FL 32801
City, State and Zip Code:

 


Part II – Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 

x    

  (a)   The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
  (b)   The subject annual report, semi-annual report, transition report on Form 10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
  (c)   The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

2



Part III – Narrative

State below in reasonable detail the reasons why the Form 10-K, 10-KSB, 11-K, 20-F, 10-Q, 10-QSB, N-SAR or portion thereof could not be filed within the prescribed time period.

The Registrant could not complete the Form 10-Q within the prescribed time because the Registrant effected numerous dispositions of physician practices during the quarter resulting in the need for additional time to complete the associated accounting and financial reporting.

 


Part IV – Other Information

 

(1) Name and telephone number of person to contact in regard to this notification:

 

Mark Szporka      (407)    367-0944
(Name)      (Area Code)    (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify the report(s):     x   Yes     ¨   No

 

 

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?     x   Yes     ¨   No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The financial statements of the Registrant for the three and nine months ended September 30, 2007 are included herein. A detailed explanation of the change between the foregoing periods and the corresponding periods in the prior fiscal year is contained in the Registrant’s Form 10-Q for the three months ended September 30, 2007, which was filed with the Securities and Exchange Commission immediately after the filing of this Form 12b-25.

 

3


PAINCARE HOLDINGS, INC.

Consolidated Balance Sheets

As of September 30, 2007 and December 31, 2006

 

     September 30,
2007
    December 31,
2006
 
Assets     

Current Assets

    

Cash

   $ 434,766     $ 2,414,160  

Accounts receivable, net

     6,506,304       8,013,638  

Note receivable

     968,706       500,000  

Deposits, prepaids and other

     884,687       552,183  

Deferred tax asset

     14,052,953       1,605,278  

Income tax receivable

     1,525,318       4,135,375  

Current assets of discontinued operations

     —         13,898,821  
                

Total current assets

     24,372,734       31,119,455  

Property and equipment, net

     6,956,927       7,949,791  

Goodwill, net

     32,362,550       48,685,270  

Other assets

     993,753       3,602,071  

Non-current assets of discontinued operations

     —         72,597,394  
                

Total assets

   $ 64,685,964     $ 163,953,981  
                
Liabilities and Stockholders’ Equity     

Current liabilities

    

Accounts payable and accrued expenses

   $ 6,732,193     $ 4,035,538  

Interest payable

     3,367,842       781,971  

Acquisition consideration payable

     659,575       4,026,209  

Current portion of notes payable

     7,819,663       34,053,378  

Convertible debentures

     12,983,796       12,415,480  

Current portion of default put option

     600,000       600,000  

Current portion of capital lease obligation

     1,098,369       1,374,030  

Total current liabilities of discontinued operations

     —         2,311,839  
                

Total current liabilities

     33,261,438       59,598,445  

Capital lease obligations

     1,142,897       1,696,642  

Deferred tax liability, non-current

     14,052,953       3,048,760  

Non-current liabilities of discontinued operations

     —         67,355  
                

Total liabilities

     48,457,288       64,411,202  
                

Minority interest related to discontinued operations

       2,191,797  

Shareholders’ equity

    

Common stock, $.0001 par value. Authorized 200,000,000 shares; issued and outstanding 67,648,717 and 66,292,721 shares, respectively

     6,765       6,629  

Preferred stock, $.0001 par value. Authorized 10,000,000 shares; issued and outstanding -0- shares

     —         —    

Additional paid in capital

     143,999,041       142,763,156  

Retained earnings

     (127,905,841 )     (45,465,595 )

Other comprehensive income

     128,711       46,792  
                

Total stockholders equity

     16,228,676       97,350,982  
                

Total liabilities and stockholders’ equity

   $ 64,685,964     $ 163,953,981  
                

 

4


PAINCARE HOLDINGS, INC.

Consolidated Statements of Operations

For the Three and Nine Months Ended September 30, 2007 and 2006 (unaudited)

 

     For the three months ended
September 30,
    For the nine months ended
September 30,
 
     2007     2006     2007     2006  

Consolidated Statement of Operations

        

Revenues:

        

Pain Mgmt.

   $ 3,560,198     $ 4,166,093     $ 12,212,591     $ 13,565,575  

Surgery

     775,899       1,189,135       2,258,355       4,027,780  

Ancillary

     1,828,616       2,296,655       7,294,691       9,892,769  
                                

Total Revenues

     6,164,713       7,651,883       21,765,637       27,486,124  

Cost of revenues

     3,290,924       2,873,577       10,273,478       7,407,288  
                                

Gross profit

     2,873,789       4,778,306       11,492,159       20,078,836  

General and administrative expense

     6,655,957       8,345,006       22,221,145       17,118,583  

Amortization expense

     344,054       165,609       372,324       466,753  

Impairment

     9,386,893       —         19,328,879       —    

Depreciation expense

     391,571       394,396       1,168,426       1,146,060  
                                

Operating income (loss)

     (13,904,686 )     (4,126,705 )     (31,598,615 )     1,347,440  

Interest income (expense)

     (2,094,406 )     (1,588,985 )     (5,371,185 )     (3,625,849 )

Derivative benefit

     —         8,558       —         10,501,509  

Other income (expense)

     (65,798 )     43,589       (77,232 )     418,262  
                                

Income (loss) from continuing operations before income taxes

     (16,064,890 )     (5,663,543 )     (37,047,032 )     8,641,362  

Provision (benefit) for income taxes

     700,259       165,571       (1,186,194 )     1,958,900  
                                

Income (loss) from continuing operations, net of tax

     (16,765,149 )     (5,829,114 )     (35,860,838 )     6,682,462  
                                

Discontinued operations:

        

Income (loss) from discontinued operations (less applicable

     —         —         —         —    

income tax (provision) benefit of ($0), ( $1,529,919), ($10,129), ($4,897,785))

     (975,546 )     1,718,946       (12,673,145 )     5,883,061  

Loss on disposal of discontinued operations

     (2,304,617 )     —         (33,906,263 )     —    
                                

Income (loss) from discontinued operations, net of tax

     (3,280,163 )     1,718,946       (46,579,408 )     5,883,061  

Income (loss) from operations before a cumulative effect of a change in accounting principle

     (20,045,312 )     (4,110,168 )     (82,440,246 )     12,565,523  
                                

Cumulative effect of a change in accounting principle (net of tax of $661,283)

     —         —         —         991,925  
                                

Net income (loss)

   $ (20,045,312 )   $ (4,110,168 )   $ (82,440,246 )   $ 13,557,448  
                                

Basic income (loss) per common share:

        

Income (loss) from continuing operations before cumulative effect of a change in accounting principle

   $ (.25 )   $ (.09 )   $ (.53 )   $ .10  

Income (loss) from discontinued operations

   $ (.05 )   $ .03     $ (.69 )   $ .09  

Cumulative effect of a change in accounting principle

     —         —         —       $ .02  
                                

Net income (loss)

   $ (.30 )   $ (.06 )   $ (1.22 )   $ .21  
                                

Diluted income (loss) per common share:

        

Income (loss) from continuing operations before cumulative effect of a change in accounting principle

   $ (.25 )   $ (.09 )   $ (.53 )   $ .09  

Income (loss) from discontinued operations

   $ (.05 )   $ .03     $ (.69 )   $ .08  

Cumulative effect of a change in accounting principle

     —         —         —       $ .01  
                                

Net income (loss)

   $ (.30 )   $ (.06 )   $ (1.22 )   $ .18  
                                

Basic weighted average common shares outstanding

     67,563,753       64,482,619       67,061,322       64,040,150  

Diluted weighted average common shares outstanding

     67,563,753       64,482,619       67,061,322       74,166,535  

 

5


PAINCARE HOLDINGS, INC.

(Name of Registrant as specified in charter)

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 13, 2007    By:  

/s/ Mark Szporka

   Name:   Mark Szporka
   Title:   Chief Financial Officer

 

6

Paincare (AMEX:PRZ)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Paincare
Paincare (AMEX:PRZ)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Paincare